Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

2000px-food_and_drug_administration_logo

FDA approves AstraZeneca’s gout drug Zurampic

December 23, 2015 Sales and Marketing AstraZeneca, FDA, Zurampic, gout, lensinurad

The US FDA has approved AstraZeneca’s Zurampic to treat high levels of uric acid in the blood. The drug is …
News
Janssen Velcade

NICE recommends Velcade for MCL, and three diabetes drugs

December 23, 2015 Sales and Marketing Forxiga, NICE, Velcade, invokana, jardiance, mantel cell lymphoma, mcl

NICE has published final guidance recommending Velcade (bortezomib) as a treatment for previously untreated mantle cell lymphoma (MCL).  In the …
News
Actelion building

Actelion ready to launch Uptravi after FDA approval

December 22, 2015 Research and Development, Sales and Marketing Actelion, FDA, Jean-Paul Clozel, Uptravi, pulmonary arterial hypertension, selexipag

Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …
News
Flemming Ornskov

Shire moves to seal Baxalta deal with improved offer

December 22, 2015 Research and Development, Sales and Marketing Baxalta, Flemming Ornskov, Shire

Shire is set to sweeten its $30 billion bid for Baxalta by offering 40% of the total, or $12 billion, …
News

Former Cubist chief executive Michael Bonney to chair board at Alnylam

December 22, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Alnylam, David Pyott, michael bonney

Michael Bonney, current board member and former chief executive of Cubist Pharmaceuticals, has been appointed as chairman of Alnylam Pharmaceuticals …
Appointment
sir_kent_woods

EMA management board chair stands down

December 21, 2015 Manufacturing and Production, Sales and Marketing EMA, European Medicines Agency, Sir Kent Woods

Sir Kent Woods will step down as chair of the board at the EMA from the end of December 2015. …
Appointment

Novartis completes purchase of rights to GSK drug for up to $1bn

December 21, 2015 Manufacturing and Production, Research and Development, Sales and Marketing

Novartis has completed the acquisition of all outstanding rights to Arzerra from GSK for up to $1.034 billion. The deal, …
News
Pfizer sign

Experts predict pharma sector to remain strong in 2016

December 21, 2015 Sales and Marketing marketing, pharma, profits, sales

The year 2016 is set to see continued growth in research and development productivity, with significant new drug launches and …
News
Ionis logo

ISIS Pharma changes name to Ionis to avoid ‘distracting’ militant association

December 21, 2015 Sales and Marketing Ionis, Isis Pharmaceuticals, branding, marketing, rebrand

After months of discussion, ISIS Pharmaceuticals has changed its name to Ionis to free itself from the fear of confusion …
News
580x381_merck_opens_its_office_in_nigeria_3_tcm2432_145041

Merck on the march in Africa

December 21, 2015 Sales and Marketing Africa, Merck, marketing, sales, strategy

When Merck unveiled its Africa 2020 strategy in November, there was no shortage of ambition.The company announced plans to expand …
Feature
EU flag

Three AstraZeneca drugs recommended by EMA committee

December 21, 2015 Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …
News
shkreli_thumb

Martin Shkreli resigns from Turing

December 21, 2015 Sales and Marketing Martin Shkreli, Shkreli, Turing Pharmaceuticals

Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing and been replaced by …
Appointment
paris_alternate_high-res_web

Ariad names EMD Serono’s Paris Panayiotopoulos as new president and chief exec

December 21, 2015 Sales and Marketing Ariad, Ariad Pharmaceuticals, EMD Serono, Paris Panayiotopoulos, harvey Berger

The board of directors at Ariad Pharmaceuticals has appointed Paris Panayiotopoulos as president and chief executive from 1 January 2016. …
Appointment
Gilead sign

Gilead steps in to rescue Galapagos RA drug

December 18, 2015 Sales and Marketing AbbVie, Gilead, Gilead Sciences, filgotinib, inflammation, inflammatory diseases, rheumatoid arthritis

Gilead Sciences is to pay $725million for the rights to filgotinib, a JAK1-selective inhibitor for rheumatoid arthritis and other inflammatory …
News
Imlygic

European approval for Amgen cancer drug Imlygic

December 18, 2015 Sales and Marketing Amgen, European Commission, Imlygic, melanoma, skin cancer, t-vec, talimogene laherparepvec

The European Commission has approved the use of Amgen’s Imlygic for adults with advanced melanoma, making it the first drug …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026